Efficacy assessment of UVA1 and narrowband UVB for treatment of scalp psoriasis.
Zhou J, Yi X, Li Y, Ding Y
To compare the efficacy and safety of UVA1 and narrowband UVB (NB-UVB) therapy in the treatment of scalp psoriasis. Patients with scalp psoriasis were... Read More
Treatment Effects upon Prolactin and Soluble Receptor of Interleukin-2 in Psoriatic Patients.
Botezatu D, Tovaru M, Georgescu SR, Curici A, Giurcaneanu C
Psoriasis vulgaris is a chronic inflammatory hyper-proliferative disease of the skin, scalp, nails, and joints. It has been hypothesized that prolacti... Read More
Curr Rheumatol Rep
Epidemiology of Psoriasis and Psoriatic Arthritis in Italy-a Systematic Review.
Prignano F, Rogai V, Cavallucci E, Bitossi A, Hammen V, Cantini F
Understanding prevalence of diseases within specific regions of a country is important for optimal allocation of healthcare resources/funds. We perfor... Read More
J. Am. Acad. Dermatol. 2018 May 24
Maintenance of Skin Clearance With Ixekizumab Treatment of Psoriasis: Three-Year Results From the UNCOVER-3 Study.
Leonardi C, Maari C, Philipp S, Goldblum O, Zhang L, Burkhardt N, Ball S, Mallbris L, Gonzalez P, Fernández-Peñas P, Puig L
Psoriasis, a chronic disease, may require long-term treatment. Ixekizumab, a high-affinity monoclonal antibody that selectively targets interleukin-17... Read More
Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials.
Foley P, Gordon K, Griffiths CEM, Wasfi Y, Randazzo B, Song M, Li S, Shen YK, Blauvelt A
Psoriasis of the scalp, palms and/or soles, and nails is challenging to treat.... Read More